Precision, compliance, and expertise for the most demanding medical and pharmaceutical content.
Into23 provides specialized translation and localization services for the life sciences sector, ensuring your clinical trial documentation, regulatory submissions, and patient-facing materials meet the stringent requirements of APAC markets. Our AI-powered, human-verified workflow combines cutting-edge technology with subject matter experts who understand the nuances of medical and pharmaceutical content. We are ISO 9001 & 17100 certified, guaranteeing a rigorous quality assurance process that you can trust for your most critical projects.
Our quality management system is certified to ISO 9001 and ISO 17100 standards, with ISO 27001 in progress, ensuring every translation undergoes a rigorous, multi-step verification process for accuracy and compliance.
Your content is handled by a curated network of professional linguists with advanced degrees and extensive experience in medicine, pharmacology, and medical device technology.
Navigate the complex regulatory landscape of Asia-Pacific with confidence. Our teams in Hong Kong, Beijing, Shanghai, Bangalore, and Tokyo provide up-to-date insights on local requirements.
We leverage customized neural machine translation engines trained on medical-specific corpora, which are then meticulously reviewed and refined by human experts to accelerate timelines and reduce costs.
From clinical trial protocols and informed consent forms (ICFs) to marketing materials and medical device manuals, we handle a full spectrum of life sciences documentation.
We ensure that patient-facing materials, such as educational content and package inserts, are translated with cultural sensitivity and clarity to improve health literacy and patient outcomes.
We analyze your source documents, establish a dedicated project team, and create a client-specific termbase and translation memory to ensure consistency.
Our custom-trained neural machine translation engines perform the initial translation, providing a high-quality baseline for our human experts.
A subject matter expert linguist meticulously reviews and refines the AI output, ensuring clinical accuracy, correct terminology, and natural phrasing.
A second, independent linguist performs a full review of the edited translation against the source text, verifying compliance with ISO 17100 standards.
The finalized, certified translations are delivered in your desired format, and we incorporate your feedback into our systems for continuous improvement.
A leading Contract Research Organization (CRO) partnered with Into23 to translate a full suite of clinical trial documentation for a pivotal Phase III study launching simultaneously in Japan, China, South Korea, Taiwan, and Australia. By leveraging our AI-powered workflow and in-country regulatory experts, we delivered fully compliant, translated, and back-translated documents 35% faster than their previous vendor, enabling an on-schedule trial start across all sites.
Get a custom quote for your translation project. Our team typically responds within 24 hours.